Inhibits antioxidant enzymes, manganese superoxide dismutase, glutathione peroxidase 2, and thioredoxin reductase 2 in prostate cancer cell lines, sensitizing them to ionizing radiation. Improves radiotherapy for aggressive tumors, including advanced prostate cancer. This evidence concerns the gene GPX2 and prostate cancer.